natgillin/translations-raw huggingface dataset:
Italien - Augmentin, Neoduplamox, Clavulin Letland - Augmentin 
Italy - Augmentin, Neoduplamox, Clavulin Latvia - Augmentin
250 mg/25 mg, 500 mg/50 mg, 1000 mg/100 mg pulver til injektions- og infusionsvæske, opløsning Augmentin bør rekonstitueres i henhold til ovenstående beskrivelse for injektionsvæsker. 
250 mg/25 mg, 500 mg/50 mg, 1000 mg/100 mg powder for solution for injection or infusion Augmentin should be reconstituted as described above for injection.
Vigtig information om nogle af de øvrige indholdsstoffer i Augmentin Augmentin indeholder aspartam (E 951) som er en kilde til fenylalanin. 
portant information about some of the ingredients of Augmentin 951) which is a source of phenylalanine.
Krystaluri9 
Crystalluria9
Hos patienter med nedsat nyrefunktion, bør dosis justeres i henhold til kreatininclearance (se pkt. 
In patients with renal impairment, the dose should be adjusted according to the degree of impairment (see section 4.2).
• Allergiske reaktioner (se ovenstående) • Betændelse i tyktarmen (se ovenstående) 
• Allergic reactions (see a bove) In mation of the large intestine (see above)
Indgivet dosis 
Dose administered
Følgende information er kun tiltænkt medicinsk- og sundhedsfaglige personer. 
The following information is intended for medical or healthcare professionals only: Please refer to the Summary of Product Characteristics for further information Administration
Arveligt resistente organismer Aerobe gramnegative mikroorganismer Acinetobacter sp. 
Inherently resistant organisms Aerobic Gram-negative micro-organisms Acinetobacter sp.
Her skal der tages hensyn, hvis De er på natriumfattig diæt. 
This should be considered if you are on a controlled sodiu m diet.
125 mg/62,5 mg/5 ml pulver til oral suspension 11 Misfarvning af tænder er meget sjældent rapporteret hos børn. 
125 mg/62.5 mg/5 ml powder for oral suspension 11 Superficial tooth discolouration has been reported very rarely in children.
- Omfattende rødt udslæt med små pusholdige blærer (bulløs exfoliativ dermatitis) 
- widespread red skin rash with small pus-containing blisters (bullous exfoliative bumps under the skin and blisters (exanthemous pustulosis).
ANVENDELSESMÅDE OG ADMINISTRATIONSVEJ(E) Oral brug 
METHOD AND ROUTE(S) OF ADMINISTRATION Oral use
Kramper kan forekomme hos patienter med nedsat nyrefunktion eller hos patienter, der får høje doser (se pkt. 
Convulsions may occur in patients with impaired renal function or in those receiving high doses (see
Dosisreduktion er ikke nødvendig hos patienter med en kreatininclearance (CrCl) på mere end 30 ml/min. 
No dose adjustment is necessary for patients with creatinine clearance (CrCl) greater than 30 ml/min.
For operationer på mindre end 1 time, er den anbefalede dosis for Augmentin 1000 mg/200 mg, som gives lige før bedøvelse (soder på 2000 mg/200 mg kan opnås ved brug af en alternativ intravenøs formulering af Augmentin). 
For procedures less than 1 hour in duration, the recommended dose of Augmentin is 1000 mg/200 mg to 2000 mg/200 mg given at induction of anaesthesia (Doses of 2000 mg/200 mg can be achieved by using an alternative intravenous formulation of Augmentin).
Kolestatisk gulsot7 
Cholestatic jaundice7
Augmentin indeholder [Udfyldes nationalt] 
FURTHER INFORMATION What Augmentin contains [To be completed nationally]
5 Grænseværdierne i tabellen er baseret på benzylpenicillins grænseværdier. 
5 Breakpoint values in the table are based on Benzylpenicillin breakpoints.
Initial dosis på 1000 mg/200 mg og herefter 500 mg/100 mg hver 24. time, plus en dosis på 500 mg/100 mg i slutningen af dialysen (da såvel amoxicillin som clavulansyre fjernes delvis under dialysen). 
Initial dose of 1000 mg/200 mg and then followed by 500 mg/100 mg every 24 hours, plus a dose of 500 mg/100 mg at the end of dialysis (as serum concentrations of both amoxicillin and clavulanic acid are decreased)
Gram-negative anaerober Gram-positive anaerober 
Gram-negative Anaerobes1 Gram-positive Anaerobes1
Generelt modtagelige stammer Aerobe grampositive mikroorganismer Enterococcus faecali 
Aerobic Gram-positive micro-organisms Enterococcus faecalis
100 mg/12,5 mg/ml pulver til oral suspension Frankrig - Augmentin 
100 mg/12.5 mg/ml powder for oral suspension France - Augmentin
Portugal - Augmentin Forte, Clavamox, Noprilam, Penilam Forte Sverige - Spektramox 
Portugal - Augmentin Forte, Clavamox, Noprilam, Penilan Forte Sweden - Spektramox
Hud og subkutane væv7 Hududslæt 
Skin and subcutaneous tissue disorders 7 Skin rash
6 Disse bivirkningr er observeret med andre penicilliner og cefalosporiner (se pkt. 
6 These events have been noted with other penicillins and cephalosporins (see section 4.4).
Dette lægemiddel indeholder 62,9 mg (2,7 mmol) natrium pr. hætteglas. 
This medicinal product contains 62.9 mg (2.7 mmol) of sodium per per vial or bottle.
• Tabletterne har en delekærv, så man kan dele tabletten for at hjælpe med at synke tabletterne. 
• Augmentin tablets have a breakline to aid breaking the tablets into two halves.
Streptococcus pyogenes og andre beta-hæmolytiske streptokokker Streptococcus viridans gruppe 
Streptococcus pyogenes and other beta-hemolytic streptococci Streptococcus viridans group
Denne Augmentinformulering er ikke velegnet, når der er høj risiko for, at de formodede patogener har nedsat følsomhed eller er resistente over for betalaktamaser, hvor den nedsatte følsomhed eller resistens ikke skyldes betalaktamaser som er følsomme for hæmning af clavulansyre (f.eks. penicillinresistente S. pneumoniae). 
This presentation of Augmentin is not suitable for use when there is a high risk that the presumptive pathogens have reduced susceptibility or resistance to beta-lactam agents that is not mediated by betalactamases susceptible to inhibition by clavulanic acid (e.g. penicillin-insusceptible S. pneumoniae).
Irland - Augmentin Duo, Augmentin Letland - Augmentin 
Ireland - Augmentin Duo, Augmentin Latvia - Augmentin
Malta - Augmentin, Noprilam Nederlandene - Augmentin, Amoxicilline/clavulaazuur Polen - Augmentin 
Malta - Augmentin, Noprilam Netherlands - Augmentin, Amoxicilline/clavulaanzuur Poland - Augmentin
- De har haft en alvorlig allergisk reaktion over for andre antibiotika. 
• if you have ever had a severe allergic (hypersensitive) reaction to any other antibiotic.
875 mg/125 mg filmvoertrukne tabletter Østrig - Augmentin, Clavamox 
875 mg/125 mg film-coated tablets Austria - Augmentin, Clavamox
Til børn på 6 år eller under bør der fortrækkes en behandling med Augmentin suspenion eller brev til børn. 
Children aged 6 years and below should preferably be treated with Augmentin suspension or paediatric sachets.
Gør behandlingen med Augmentin færdig, også selv om Deres barn har fået det bedre. 
Keep giving your child Augmentin until the treatment is finished, even if they feel better.
250 mg/25mg; 500 mg/50 mg; 1000 mg/100 mg pulver til injektions- og infusionsvæske, opløsning Det anbefales ikke at bruge Augmentin med amoxicillin og clavulansyre i forholdet 10:1 til patienter med et kreatinin-clearance på under 30 ml/min, da det ikke er muligt at justere dosis. 
250 mg/25 mg; 500 mg/50 mg, 1000 mg/100 mg powder for solution for injection or infusion In patients with creatinine clearance less than 30 ml/min, the use of Augmentin presentations with an amoxicillin to clavulanic acid ratio of 10:1 is not recommended, as no dose adjustments are available.
250 mg/125 mg filmovertrukne tabletter Augmentin tabletter anbefales ikke 
250 mg/125 mg film-coated tablets Augmentin tablets are not recommended.
Eliminationshalveringstiden af amoxicillin er den samme hos børn fra ca. 3 mdr. 
The elimination half-life of amoxicillin is similar for children aged around 3 months to 2 years and older children and adults.
125 mg/62,5 mg/5 ml pulver til oral suspension Irland - Augmentin, Clavamel 
125 mg/62.5 mg/5 ml powder for oral suspension Ireland - Augmentin, Clavamel
Der foreligger ingen kliniske data af Augmentinformuleringer i forholdet 7:1 til børn under 2 måneder. 
There are no clinical data for Augmentin 7:1 formulations for patients under 2 months of age.
500 mg/125 mg pulver til oral suspension i breve Den normale dosis er: 
500 mg/125 mg powder for oral suspension in sachets The usual dose is:
1000 mg/200 mg pulver til injektions- og infusionsvæske, opløsning Augmentin bør rekonstitueres i henhold til ovenstående beskrivelse for injektionsvæsker. 
1000 mg/200 mg powder for solution for injection or infusion Augmentin should be reconstituted as described above for injection.
125 mg/62,5 mg/5 ml pulder til oral suspension Dette lægemiddel indeholder maltodextrin (glucose) og bør ikke anvendes til patienter med glucose/galactosemalabsorption. 
125 mg/62.5 mg/5 ml powder for oral suspension This medicinal product contains maltodextrin (glucose).
Augmentin 250 mg/25 mg bør opløses i 5 ml solvent. 
Augmentin 250 mg/25 mg should be dissolved in 5 ml of solvent.
200 mg/28,5 mg/5 ml pulver til oral suspension Finland - Clavurion 
200 mg/28.5 mg/5 ml powder for oral suspension Finland - Clavurion
20 mg/5 mg/kg/dag til 60 mg/15 mg/kg/dag fordelt på tre doser. 
20 mg/5 mg/kg/day to 60 mg/15 mg/kg/day given in three divided doses.
Hvis De glemmer at give Deres barn en dosis, så giv den så snart De kommer i tanker om det, men De må ikke give Deres barn en dosis for hurtigt. 
If you forget to give your child a dose, give it as soon as y child the next dose too soon, but wait about 4 hour
• Tand infektioner 
• dental infections
Den mest almindelige rapporterede bivirkning er diarré, kvalme og opkastning. 
The most commonly reported adverse drug reactions (ADRs) are diarrhoea, nausea and vomiting.
[Udfyldes nationalt] 
pleted nationally]
Augmentin bruges til voksne og børn til behandling af følgende sygdomme: 
Augmentin is used in adults and children to treat the following infections:
Nedenstående doser udtrykkes i i indholdet af amoxicillin/clavulansyres indhold med undtagelse af doser, hvor enkeltstof er angivet. 
Doses are expressed throughout in terms of amoxicillin/clavulanic acid content except when doses are stated in terms of an individual component.
Frankrig - Augmentin IV 
France - Augmentin IV
Hvis De holder op med at tage Augmentin 
If you stop taking Augmentin
250 mg/125 mg filmovertrukne tabletter Den sædvanlige dosis er: 
250 mg/125 mg film-coated tablets The usual dose is:
• Stærkt nedsat af antal af hvide blodlegemer 
• severe reduction in the number of white blood cells
Hvis De har glemt at tage Augmentin 
If you forget to take Augmentin
1 Denne formulering af amoxicillin/clavulansyre er ikke egnet til behandling af Streptococcus pneumoniea, da de er resistente overfor penicillin (se pkt. 
1 This presentation of amoxicillin/clavulanic acid may not be suitable for treatment of Streptococcus pneumoniae that are resistant to penicillin (see sections 4.2 and 4.4).
Arveligt resistente organismer Aerobe gramnegative mikroorganismer 
Inherently resistant organisms Aerobic Gram-negative micro-organisms
125 mg/62,5 mg/5 ml pulver til oral suspension • Normal dosering - 9 mg/4,5 mg op til 18 mg/9 mg pr kg kropsvægt pr. dag fordelt på 3 doser. 
12 g/62.5 mg/5 ml powder for oral suspension Usual dose - 9 mg/4.5 mg to 18 m g/9 mg for each kilogram of body weight a day, given in three divided doses.
Voksne og børn, der vejer over 40 kg 
Adults and children weighing 40 kg and over
 Kontakt straks lægen, hvis De oplever nogen af ovenstående symptomer. 
Contact a doctor immediately if you get any of these symptoms.
doser inden for 1 time. 
Do not give 2 doses in 1 hour.
Portugal - Augmentin, Clavamox, Noprilam, Penilam Spanien - Clavumox 
Portugal - Augmentin, Clavamox, Noprilam, Penilan Spain - Clavumox
Hos patienter med nedsat nyrefunktion skal dosis derfor justeres for at undgå akkumulation af amoxicillin og stadig opretholde et tilstrækkeligt clavulansyre niveau (se pkt. 
Doses in renal impairment must therefore prevent undue accumulation of amoxicillin while maintaining adequate levels of clavulanic acid (see section 4.2).
Hos patienter med blærekateter bør katetrets funktion kontrolleres regelmæssigt (se pkt. 
In patients with bladder catheters, a regular check of patency should be maintained (see section 4.9).
Inden behandling med amoxicillin/clavulansyre påbegyndes, skal patienten omhyggeligt udspørges om tidligere overfølsomhedsreaktioner over for penicilliner, cefalosporiner eller andre betalaktamantibiotika. 
Before initiating therapy with amoxicillin/clavulanic acid, careful enquiry should be made concerning previous hypersensitivity reactions to penicillins, cephalosporins or other beta-lactam agents.
Andre bivirkninger Andre bivirkninger er observeret hos meget få patienter, så frekvensen er ukendt. 
Other side effects d in a very small number of people but their exact frequency is
Farmakokinetisk gennemsnitsparametre (± SD) Bolus intravenøs injektion 
Bolus intravenous injection
Deres barn får bivirkninger, som ikke er nævnt her. 
you notice any side effects not listed
• Hævelse, nogle gange af ansigt eller mund (angioødem), der kan give vejrtrækningsproblemer. 
• swelling, sometimes of the face or mouth (angioedema), causing difficulty in breathing
Anbefalde doser til behandling af de infektioner nævnt i pkt. 
Recommended doses for treatment of infections as indicated in section 4.1:
Portugal - Augmentin Duo, Clavamox DT, Noprilam DT, Penilam DT Rumænien - Augmentin 
Portugal - Augmentin Duo, Clavamox DT, Noprilam DT, Penilan DT Romania - Augmentin
Ungarn - Augmentin, Augmentin Duo Island - Augmentin 
Hungary - Augmentin, Augmentin Duo Iceland - Augmentin
• Børn på 3 mdr. 
f children.
500 mg/125 mg filmovertrukne tabletter Den sædvanlige dosis er: 
500 mg/125 mg film-coated tablets The usual dose is:
Kontroller at kapslens forsegling er intakt før brug Tilsæt 91 ml vand 
Check cap seal is intact before use Add 91 ml of water Invert and shake well
6 En moderat øgning i ASAT og/eller ALAT er konstateret hos patienter behandlet med betalaktamantibiotika. 
6 A moderate rise in AST and/or ALT has been noted in patients treated with beta-lactam class antibiotics, but the significance of these findings is unknown.
CrCl: 10-30 ml/min 25 mg/5 mg/kg gives hver 12. time CrCl < 10 ml /min 
CrCl: 10 to 30 ml/min 25 mg/5 mg per kg given every 12 hours CrCl < 10 ml /min
500 mg/125 mg opløselige tabletter Østrig - Sugmentin, Clavamox Tyskland - Augmentan Grækenland - Augmentin 
500 mg/125 mg dispersible tablets Austria - Augmentin, Clavamox Germany - Augmentan Greece
500 mg/100 mg pulver til injektions- og infusionsvæske, opløsning Augmentin bør rekonstitueres i henhold til ovenstående beskrivelse for injektionsvæsker. 
500 mg/100 mg powder for solution for injection or infusion Augmentin should be reconstituted as described above for injection.
Det kannormalt fjernes ved tandbørstning Bivirkninger, der kan vise sig i blodprøver eller urinprøver 
• stained teeth (in children), usually removed by brush Side effects that may show up in your blood or urine tests:
Batch: 
names:
To doser på 250 mg/125 mg hver 24. time, plus to doser på 250 mg/125 mg under dialyse, og gentaget ved dialyseafslutning (da koncentrationerne af både amoxicillin og clavulansyre formindskes under dialyse). 
Two doses of 250 mg/125 mg every 24 hours, plus two doses of 250 mg/125 mg during dialysis, to be repeated at the end of dialysis (as serum concentrations of both amoxicillin and clavulanic acid are decreased)
Udfældning af amoxicillin i blærekateter er rapporteret, fortrinsvis efter i.v. 
Amoxicillin has been reported to precipitate in bladder catheters, predominantly after intravenous administration of large doses.
bør kun administreres Augmentin som infusion. 
Children aged less than 3 months should be administered Augmentin by infusion only.
500 mg/125 mg filmvoertrukne tabletter Østrig - Augmentin, Clavamox Belgien - Augmentin 
500 mg/125 mg film-coated tablets Austria - Augmentin, Clavamox Belgium - Augmentin
Nederlandene - Augmentin, Amoxicilline/clavulaazuur Polen - Augmentin 
Netherlands - Augmentin, Amoxicilline/clavulaanzuur Poland - Augmentin
CrCl: 10-30 ml/min Initial dosis på 1000 mg/200 mg og herefter 500 mg/100 mg 2 gange daglig CrCl < 10 ml /min 
CrCl: 10-30 ml/min Initial dose of 1000 mg/200 mg and then 500 mg/100 mg given twice daily CrCl < 10 ml /min
875 mg/ 125 mg og 400 mg/ 57mg pulver til oral suspension i brev; 200 mg/28,5 mg/ml og 400 mg/ 57 mg/ 5 ml pulver til oral suspension 
875 mg/125 mg and 400 mg/57 mg powder for oral suspension in sachets; 200 mg/28.5 mg/ml and 400 mg/57 mg/5 ml powder for oral suspension
Nedenstående viser de farmakokinetiske resultater for amoxicillin/clavulansyre administreret som bolus intravenøs injektion i styrkeforholdene 500 mg/100 mg eller 1000 mg/200 mg og 2000 mg/200 mg givet til en gruppe raske frivillige personer. 
The pharmacokinetic results for studies in which amoxicillin/clavulanic acid was administered to groups of healthy volunteers as either 500 mg/100 mg or 1000 mg/200 mg given as a bolus intravenous injection are presented below.
Fortæl det altid til lægen eller på apoteket, hvis Deres barn bruger anden medicin eller har brugt det for nylig. 
Please tell your doctor or pharmacist if your child is taking or has recently taken any other medicines.
125 mg/31,25 mg/5 ml pulver til oral suspension Østrig - Clavamox 
125 mg/31.25 mg/5 ml powder for oral suspension Austria - Clavamox
Hvis De glemmer at tage en dosis, så tag den så snart De kommer i tanker om det, men De må ikke tage Deres dosis for hurtigt. 
If you forget to take a dose, take it as soon as you rem soon, but wait about 4 hours before taking the next dose.
Mean peak serum konc. 
Dose Mean peak serum conc (g/ml)
Cypern - Augmentin, Noprilam DT Tjekkiet - Augmentin 
Cyprus - Augmentin, Noprilam DT Czech Republic - Augmentin
• 25 mg/3,6 mg/kg/dag til 45 mg/6,4 mg/kg/dag fordelt på to doser. 
• 25 mg/3.6 mg/kg/day to 45 mg/6.4 mg/kg/day given as two divided doses;
250 mg/25 mg pulver til injektions- og infusionsvæsker, opløsning Dette lægemiddel indeholder 15,7 mg (0,7 mmol) natrium pr. hætteglas. 
250 mg/25 mg powder for solution for injection or infusion This medicinal product contains 15.7 mg (0.7 mmol) of sodium per vial.
875 mg/125 mg filmovertrukne tabletter 875 mg/125 mg pulver til oral suspension i brev Diarré 
875 mg/125 mg film-coated tablets 875 mg/125 mg powder for oral suspension in sachets Diarrhoea
600 mg/42,9 mg/5 ml pulver til oral suspension 
600 mg/42.9 mg/5 ml powder for oral suspension
Hvis De er i tvivl, om et af ovenstående punkter gælder for Dem, skal de kontakte lægen eller apoteket, før De begynder at tage Augmentin. 
If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking Augmentin.
500 mg/62,5 mg filmovertrukne tabletter 
500 mg/62.5 mg film-coated tablets
Bivirkninger, der kan vise sig i blodprøver eller urinprøver 
Side effects that may show up in your blood or urine tests:
Staphylococcus aureus2 Koagulase-negative stapfylokokker2 
Staphylococcus aureus 2 Coagulase-negative staphylococci 2
Virkemåde 
ATION
Der findes derfor ikke noget doseringsforslag. 
Dosing recommendations in this population therefore cannot be made.
Mikroorganismer der udviser selv det mindste tegn på nedsat følsomhed overfor penicillin bør ikke behandles med denne formulering (se pkt. 
Organisms that show any degree of reduced susceptibility to penicillin should not be treated with this presentation (see sections 4.2 and
Augmentin 1000 mg/200 mg bør opløses i 20 ml solvent. 
Augmentin 1000 mg/200 mg should be dissolved in 20 ml of solvent.
Kontroller at lågets forsegling er intakt før brug Tilsæt 18 ml vand 
Check cap seal is intact before use Add 18 ml of water Invert and shake well
• Høj dosis - 1 tablet 3 gange daglig 
• Higher dose - 1 tablet three times a day
RKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE KARTON 
PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON
Gram-positive anaerober 
Gram-positive Anaerobes1
Vær ekstra forsigtig med at tage Augmentin Tal med lægen eller apoteket inden behandling hvis: - De har mononukleose (kyssesyge) 
special care with Augmentin Talk to your doctor, pharmacist or nurse before taking this medicine if you: have glandular fever are be
Det anbefales altid at anvende en enzymatisk glucose-oxidasetest til at undersøge tilstedeværelsen af glucose i urinen hos patienter i behandling med amoxicillin. 
During treatment with amoxicillin, enzymatic glucose oxidase methods should be used whenever testing for the presence of glucose in urine because false positive results may occur with nonenzymatic methods.
• Lav dosis - 2 tabletter 2 gange daglig 
• Lower dose - 2 tablets two times a day
De skal mindst vente 4 timer, før De tager den næste dosis. 
You should not take the next dose too soon, but wait about 4 hours before taking the next dose.
Danmark - Spektramox 
Denmark- Spektramox
500 mg/125 mg hver 24. time, plus 500 mg/125 mg under dialyse, og gentaget ved dialyseafslutning (da koncentrationerne af både amoxicillin og clavulansyre formindskes under dialyse). 
500 mg/125 mg every 24 hours, plus 500 mg/125 mg during dialysis, to be repeated at the end of dialysis (as serum concentrations of both amoxicillin and clavulanic acid are decreased)
400 mg/57 mg pulver til oral suspension i brev 200 mg/28,5 mg/5 ml pulver til oral suspension 400 mg/57 mg/5 ml pulver til oral suspension Diarré 
400 mg/57 mg powder for oral suspension in sachets 200 mg/28.5 mg/5 ml powder for oral suspension 400 mg/57 mg/5 ml powder for oral suspension Diarrhoea
TILLADELSEN {DD måned ÅÅÅÅ} [Udfyldes nationalt] 
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION {DD month YYYY} [To be completed nationally]
- De tidligere har fået dårlig lever eller gulsot (huden bliver gul) under behandling med antibiotika. 
• if you have ever had liver problems or jaundice (yellowing of the skin) when taking an antibiotic.
Indehaver af markedsføringstilladelsen og fremstiller [se Bilag I - udfyldes nationalt] 
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER [See Annex I - To be completed nationally]
Storbritannien - Augmentin Intravenous 
United Kingdom- Augmentin Intravenous
Det er vigtigt, at De bruger denne, for at give den mest korrekte dosis. 
You should use this to give the correct dose to your baby or child.
Denne Augmentinformulering, pulver til injektions- og infusionsvæske giver en total døgndosis på op til 6000 mg amoxicillin og 600 mg clavulansyre, når der administreres som anbefalet nedenfor. 
This Augmentin powder for solution for injection or infusion provides a total daily dose of up to 6000 mg amoxicillin and 600 mg clavulanic acid when administered as recommended below.
Augmentin 500 mg/50 mg indeholder cirka 9,8 mg (0,3 mmol) kalium. 
• Augmentin 500 mg/50 mg contains approximately 9.8 mg (0.3 mmol) of potassium.
FARMAKOLOGISKE OPLYSNINGER 
PHARMACEUTICAL PARTICULARS
1 Se pkt. 
T 1/2
Slovakiet - Augmentin Sverige - Spektramox Storbritanien - Augmentin 
Slovenia -Augmentin Spain - Augmentine, Clavumox Sweden - Spektramox United Kingdom - Augmentin
Hvis samtidig indgift er nødvendig, bør protrombintiden eller INR nøje monitoreres, når amoxicillinbehanling initieres eller seponeres. 
If coadministration is necessary, the prothrombin time or international normalised ratio should be carefully monitored with the addition or withdrawal of amoxicillin.
Storbritannien - Augmentin Duo 
Hungary - Augmentin Duo
Hvis De har taget for mange Augmentin, kan symptomerne være mavegener (kvalme, opkastning eller diarre) eller kramper. 
If you take too much Augmentin, signs might include an upset stomach (feeling sick, being sick or diarrhoea) or convulsions.
Tilsæt 19 ml vand (eller tilsæt vand i 2 portioner op til markeringsstregen) (20 ml) Tilsæt 32 ml vand (eller tilsæt vand i 2 portioner op til markeringsstregen) (35 ml) Tilsæt 64 ml vand (eller tilsæt vand i 2 portioner op til markeringsstregen) (70 ml) Tilsæt 127 ml vand (eller tilsæt vand i 2 portioner op til markeringsstregen) (140 ml) 
Add 19 ml of water (or add water in 2 portions up to the mark) (20 ml) Add 32 ml of water (or add water in 2 portions up to the mark) (35 ml) Add 64 ml of water (or add water in 2 portions up to the mark) (70 ml) Add 127 ml of water (or add water in 2 portions up to the mark) (140 ml) Invert and shake well
(µg/ml) 
(g/ml)